Industry Issues and BIO-Issues & Initiatives

GMOs (Genetically Modified Organisms)

• MEMORANDUM IN OPPOSITION OF BILLS S.6625 / A.8344:
  Mandatory Labeling Requirements for Seeds that Contain Genetically Modified Organisms
• Letter to NYS Assembly (6/02)
• Testimony to NYS Senate (9/00)

Intellectual Property

• Hatch-Waxman Reform - Letter to Senator Schumer (9/02)

SBIR (Small Business Innovative Research Program)

• NYBA Supports the Small Business Innovation Research Program
  Reauthorization Act
• Letter to NY Congressional Delegation

Stem Cells/Cloning

• Letter to Senator Clinton - Therapeutic Cloning Act (1/03)
• Letter to NYS Senate regarding support of The Reproductive Cloning Prohibition and Research Protection Act (S3013-A) (3/03)
• NYBA press release (3/03) regarding New York State Assembly Passage of Therapeutic Stem Cell Legislation
• Comment on President's Statement on Stem Cell Research, 8/02

REIMBURSEMENT ISSUES

• Federal Issue: Importation of Drugs from Canada and other Countries
  Letter to U.S. Senator Hillary Clinton opposing proposed federal legislation that would legalize drug importation from Canada.
• State Issue: Preferred Drug Program (PDP) and Pharmaceutical Price Controls
  Letter to Governor Pataki opposing proposed state legislation that would create a Preferred Drug Program in the New York Medicaid program.
• NYBA Position Statement on Drug Reimbursment
• Letter to Governor George Pataki